Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 487

    1.

    Brief communication: Preoperative anticoagulant activity after bridging low-molecular-weight heparin for temporary interruption of warfarin.

    O'Donnell MJ, Kearon C, Johnson J, Robinson M, Zondag M, Turpie I, Turpie AG.

    Ann Intern Med. 2007 Feb 6;146(3):184-7.PMID: 17283349 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Summaries for patients. Safety of surgery during bridging anticoagulation therapy with low-molecular-weight heparin.

    [No authors listed]

    Ann Intern Med. 2007 Feb 6;146(3):I35. No abstract available. PMID: 17283344 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    How useful is determination of anti-factor Xa activity to guide bridging therapy with enoxaparin? A pilot study.

    Hammerstingl C, Omran H, Tripp C, Poetzsch B.

    Thromb Haemost. 2009 Feb;101(2):325-32.PMID: 19190817 [PubMed - indexed for MEDLINE]Related articles

    4.

    Bridging anticoagulation with low-molecular-weight heparin after interruption of warfarin therapy is associated with a residual anticoagulant effect prior to surgery.

    Douketis JD, Woods K, Foster GA, Crowther MA.

    Thromb Haemost. 2005 Sep;94(3):528-31.PMID: 16268467 [PubMed - indexed for MEDLINE]Related articles

    5.

    Clinical outcomes with unfractionated heparin or low-molecular-weight heparin as bridging therapy in patients on long-term oral anticoagulants: the REGIMEN registry.

    Spyropoulos AC, Turpie AG, Dunn AS, Spandorfer J, Douketis J, Jacobson A, Frost FJ; REGIMEN Investigators.

    J Thromb Haemost. 2006 Jun;4(6):1246-52.PMID: 16706967 [PubMed - indexed for MEDLINE]Related articles

    7.

    Bridging low-molecular-weight heparin for temporary interruption of warfarin.

    Shojania AM.

    Ann Intern Med. 2007 Nov 6;147(9):671; author reply 671. No abstract available. PMID: 17975192 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Meta-analysis: low-molecular-weight heparin and bleeding in patients with severe renal insufficiency.

    Lim W, Dentali F, Eikelboom JW, Crowther MA.

    Ann Intern Med. 2006 May 2;144(9):673-84.PMID: 16670137 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Preoperative use of enoxaparin is not a risk factor for postoperative bleeding after coronary artery bypass surgery.

    Medalion B, Frenkel G, Patachenko P, Hauptman E, Sasson L, Schachner A.

    J Thorac Cardiovasc Surg. 2003 Dec;126(6):1875-9.PMID: 14688699 [PubMed - indexed for MEDLINE]Related articles

    10.

    Surgical bleeding after pre-operative unfractionated heparin and low molecular weight heparin for coronary bypass surgery.

    Renda G, Di Pillo R, D'Alleva A, Sciartilli A, Zimarino M, De Candia E, Landolfi R, Di Giammarco G, Calafiore A, De Caterina R.

    Haematologica. 2007 Mar;92(3):366-73.PMID: 17339186 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Anti-Xa activity relates to survival and efficacy in unselected acute coronary syndrome patients treated with enoxaparin.

    Montalescot G, Collet JP, Tanguy ML, Ankri A, Payot L, Dumaine R, Choussat R, Beygui F, Gallois V, Thomas D.

    Circulation. 2004 Jul 27;110(4):392-8. Epub 2004 Jul 12.PMID: 15249498 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    [Perioperative Bridging with Enoxaparin. Results of the Prospective BRAVE Registry with 779 Patients]

    Omran H, Hammerstingl C, Paar WD; Bonn Registry of Alternative Anticoagulation to Prevent Vascular Events.

    Med Klin (Munich). 2007 Oct 15;102(10):809-15. German. PMID: 17928964 [PubMed - indexed for MEDLINE]Related articles

    13.

    Anticoagulant effects of low-molecular-weight heparins in healthy cats.

    Alwood AJ, Downend AB, Brooks MB, Slensky KA, Fox JA, Simpson SA, Waddell LS, Baumgardner JE, Otto CM.

    J Vet Intern Med. 2007 May-Jun;21(3):378-87.PMID: 17552440 [PubMed - indexed for MEDLINE]Related articles

    14.

    Risk of thromboembolism with short-term interruption of warfarin therapy.

    Garcia DA, Regan S, Henault LE, Upadhyay A, Baker J, Othman M, Hylek EM.

    Arch Intern Med. 2008 Jan 14;168(1):63-9.PMID: 18195197 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen.

    Douketis JD, Johnson JA, Turpie AG.

    Arch Intern Med. 2004 Jun 28;164(12):1319-26.PMID: 15226166 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin.

    Kovacs MJ, Kearon C, Rodger M, Anderson DR, Turpie AG, Bates SM, Desjardins L, Douketis J, Kahn SR, Solymoss S, Wells PS.

    Circulation. 2004 Sep 21;110(12):1658-63. Epub 2004 Sep 13.PMID: 15364803 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Pharmacokinetics of the low molecular weight heparin enoxaparin during 48 h after bolus administration as an anticoagulant in haemodialysis.

    Guillet B, Simon N, Sampol JJ, Lorec-Penet AM, Portugal H, Berland Y, Dussol B, Brunet P.

    Nephrol Dial Transplant. 2003 Nov;18(11):2348-53.PMID: 14551364 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Effect of patient weight on the anticoagulant response to adjusted therapeutic dosage of low-molecular- weight heparin for the treatment of venous thromboembolism.

    Wilson SJ, Wilbur K, Burton E, Anderson DR.

    Haemostasis. 2001 Jan-Feb;31(1):42-8.PMID: 11408748 [PubMed - indexed for MEDLINE]Related articles

    20.

    Low-molecular-weight-heparins as periprocedural anticoagulation for patients on long-term warfarin therapy: a standardized bridging therapy protocol.

    Jaffer AK, Ahmed M, Brotman DJ, Bragg L, Seshadri N, Qadeer MA, Klein A.

    J Thromb Thrombolysis. 2005 Aug;20(1):11-6.PMID: 16133889 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data